Turning Point Therapeutics, Inc. Defined Contribution Plan, Cost
Turning Point Therapeutics, Inc. reported Defined Contribution Plan, Cost of $1.40 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2022-02-28
- Turning Point Therapeutics, Inc. defined contribution plan, cost for fiscal 2021 was $1.40M, a 75.00% increase from fiscal 2020.
- Turning Point Therapeutics, Inc. defined contribution plan, cost for fiscal 2020 was $800.00K, a 60.00% increase from fiscal 2019.
- Turning Point Therapeutics, Inc. defined contribution plan, cost for fiscal 2019 was $500.00K, a 150.00% increase from fiscal 2018.
- Turning Point Therapeutics, Inc. defined contribution plan, cost for fiscal 2018 was $200.00K, a 852.38% increase from fiscal 2017.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2021-12-31 | $1.40M 10-K · filed 2022-02-28 |
| 2020-12-31 | $800.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $500.00K 10-K · filed 2022-02-28 |
| 2018-12-31 | $200.00K 10-K · filed 2021-03-01 |
| 2017-12-31 | $21.00K 10-K · filed 2020-03-18 |